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Abstract
Following a request from the European Commission, the EFSA Panel on Additives and Products or
Substances used in Animal Feed (FEEDAP) was asked to deliver a scientiﬁc opinion on the safety and
efﬁcacy of EB15 10 for weaned piglets and minor porcine species. The additive is a preparation
containing viable spores of a strain of Bacillus subtilis intended for use in feed at the proposed dose of
5 9 108 CFU/kg complete feedingstuffs and in water for drinking at 1.7 9 108 CFU/L. The additive exists
in two forms, EB15 and EB15 10, which contain the bacterium in concentrations of 1.25 9 109 CFU/g
additive and 1.25 9 1010 CFU/g additive, respectively. The two formulations are considered equivalent
when used to deliver the same dose. B. subtilis is considered by EFSA to be suitable for the qualiﬁed
presumption of safety (QPS) approach to establishing safety. The active agent fulﬁls the requirements of
the QPS approach to the assessment of safety. Consequently, the additive can be presumed safe for the
target animals, consumers of products from treated animals and the environment. Given the
proteinaceous nature of the active agent, the additive should be considered a potential respiratory
sensitiser. In the absence of data, the FEEDAP Panel cannot conclude on the irritancy potential of the
additive to skin and eyes or its dermal sensitisation. Insufﬁcient evidence was provided to conclude on
the efﬁcacy of the additive in weaned piglets or minor weaned porcine species.
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1. Introduction
1.1. Background and Terms of Reference
Regulation (EC) No 1831/20031 establishes the rules governing the Community authorisation of
additives for use in animal nutrition. In particular, Article 4(1) of that Regulation lays down that any
person seeking authorisation for a feed additive or for a new use of a feed additive shall submit an
application in accordance with Article 7.
The European Commission received a request from Chr. Hansen A/S2 for authorisation of the
product EB15 10 (Bacillus subtilis DSM 25841), when used as a feed additive for weaned piglets and
weaned minor porcine species (category: zootechnical additives; functional group: gut ﬂora stabilisers).
According to Article 7(1) of Regulation (EC) No 1831/2003, the Commission forwarded the
application to the European Food Safety Authority (EFSA) as an application under Article 4(1)
(authorisation of a feed additive or new use of a feed additive). The particulars and documents in
support of the application were considered valid by EFSA as of 13 January 2017.
According to Article 8 of Regulation (EC) No 1831/2003, EFSA, after verifying the particulars and
documents submitted by the applicant, shall undertake an assessment in order to determine whether
the feed additive complies with the conditions laid down in Article 5. EFSA shall deliver an opinion on
the safety for the target animals, consumer, user and the environment and on the efﬁcacy of the
product EB15 10 (Bacillus subtilis DSM 25841), when used under the proposed conditions of use (see
Section 3.1.4).
1.2. Additional information
The additive EB15 10 is a preparation containing viable spores of Bacillus subtilis DSM 25841. It has
not been previously authorised as a feed additive in the European Union.
2. Data and methodologies
2.1. Data
The present assessment is based on data submitted by the applicant in the form of a technical
dossier3 in support of the authorisation request for the use of EB15 10 as a feed additive. The
technical dossier was prepared following the provisions of Article 7 of Regulation (EC) No 1831/2003,
Regulation (EC) No 429/20084 and the applicable EFSA guidance documents.
EFSA has veriﬁed the European Union Reference Laboratory (EURL) report as it relates to the
methods used for the control of the active agent in animal feed. The Executive Summary of the EURL
report can be found in Annex A.5
2.2. Methodologies
The approach followed by the FEEDAP Panel to assess the safety and the efﬁcacy of EB15 10 is in
line with the principles laid down in Regulation (EC) No 429/2008 and the relevant guidance
documents: Guidance on zootechnical additives (EFSA FEEDAP Panel, 2012a), Technical guidance:
Tolerance and efﬁcacy studies in target animals (EFSA FEEDAP Panel, 2011), Guidance on studies
concerning the safety of use of the additive for users/workers (EFSA FEEDAP Panel, 2012b), Guidance
on the assessment of the toxigenic potential of Bacillus species used in animal nutrition (EFSA FEEDAP
Panel, 2014) and Guidance on the assessment of bacterial susceptibility to antimicrobials of human
and veterinary importance (EFSA FEEDAP Panel, 2012c).
1 Regulation (EC) No 1831/2003 of the European Parliament and of the Council of 22 September 2003 on additives for use in
animal nutrition. OJ L 268, 18.10.2003, p. 29.
2 Chr. Hansen A/S, 10-12 Boege Alle, 2970 Hoersholm, Denmark.
3 FEED dossier reference: FAD-2016-0070.
4 Commission Regulation (EC) No 429/2008 of 25 April 2008 on detailed rules for the implementation of Regulation (EC)
No 1831/2003 of the European Parliament and of the Council as regards the preparation and the presentation of applications
and the assessment and the authorisation of feed additives. OJ L 133, 22.5.2008, p. 1.
5 The full report is available on the EURL website: https://ec.europa.eu/jrc/sites/jrcsh/files/ﬁnrep-fad-2016-0070-baci_subtilis.pdf
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3. Assessment
The additive is a preparation containing viable spores of B. subtilis DSM 25841 intended to be used in
feed and water for drinking for weaned piglets and minor weaned porcine species to improve growth.
3.1. Characterisation
3.1.1. Characterisation of the active agent
B. subtilis DSM 25841 was isolated from the faeces from healthy adult pigs and has not been
genetically modiﬁed.6 The strain has been deposited in the Deutsche Sammlung von Mikroorganismen
und Zellkulturen with the accession number DSM 25841.7
Taxonomical identiﬁcation of the product strain as B. subtilis was achieved using nearly complete
16S rRNA gene sequencing and multilocus sequence typing of partial sequences of the genes groEL,
gyrA, polC, purH and rpoB and comparison with reference databases. Strain-speciﬁc identiﬁcation was
based on the use of pulsed-ﬁeld gel electrophoresis after cleavage with restriction enzymes NotI and
SpeI used individually.8
B. subtilis DSM 25841 was tested for antibiotic susceptibility using two-fold broth dilutions. The
battery of antibiotics tested was that recommended by EFSA (EFSA FEEDAP Panel, 2012c).9 All
minimum inhibitory concentration values fell below the corresponding cut-off values deﬁned by the
FEEDAP Panel, therefore the strain is considered to be susceptible to relevant antibiotics.
The toxigenic potential of B. subtilis DSM 25841 was assessed according to the Technical Guidance on
the assessment of the toxigenic potential of Bacillus species used in animal nutrition (EFSA FEEDAP Panel,
2014).10 No lysis of Vero cells was detected, so B. subtilis DSM 25841 is considered to be not toxigenic.
3.1.2. Characterisation of the additive11
The manufacturing process of the additive is detailed in the dossier.12 EB15 10 is produced with a
minimum guaranteed concentration of 1.25 9 1010 colony forming units (CFU) per gram of additive.
Batch-to-batch variation was measured in ﬁve batches of the additive and found to be consistently
compliant with speciﬁcations (mean: 1.54 9 1010 CFU/g, range: 1.5–1.6 9 1010 CFU/g).13 The applicant
mentions in the dossier a second formulation called EB15 and with a minimum concentration of
1.25 9 109 CFU/g additive. This formulation was used in some stability and efﬁcacy studies.
The additive is routinely monitored for microbial and chemical contamination. Limits are set for total
coliforms (< 103 CFU/g), yeasts and ﬁlamentous fungi (< 103 CFU/g), Escherichia coli (< 10 CFU/g),
Salmonella (absent in 25 g), aﬂatoxin B1 (< 0.005 mg/kg), lead (< 5.0 mg/kg), cadmium (< 0.5 mg/kg),
mercury (< 0.1 mg/kg) and arsenic (< 2.0 mg/kg). Analyses of ﬁve batches showed compliance with the
limits set for microbial impurities13 and absence of Bacillus cereus contamination.14,15 Analyses of three
batches of the additive for chemical contamination showed values compliant with speciﬁcations or levels
not giving rise to concerns (lead ≤ 0.161 mg/kg, cadmium ≤ 0.012 mg/kg, mercury ≤ 0.014 mg/kg,
arsenic ≤ 0.059 mg/kg and aﬂatoxin B1 < 0.64 lg/kg, dioxins and polychlorinated biphenyls (PCBs):
octachlorodibenzo-p-dioxin (OCDD) ≤ 0.153 ng/kg, octachlorodibenzofuran (OCDF) ≤ 0.161 ng/kg,
WHO-polychlorinated dibenzodioxins/dibenzofurans-toxic equivalent (WHO-PCDD/F-TEQ) ≤ 0.196 ng/kg
and WHO-PCDD/F-PCB-TEQ ≤ 0.208 ng/kg.16
The particle size distribution of EB15 10 was tested in three batches by laser diffraction. Results
showed that 9% (v/v) of the additive consists of particles with diameters less than 50 lm and 4% less
6 Technical dossier/Section II/Annex II.1.3a.
7 Technical dossier/Section II/Annexes II.2.1.2a.
8 Technical dossier/Section II/Annexes II.2.1.2b and c.
9 Technical dossier/Section II/Annex II.2.2.2c.
10 Technical dossier/Section II/Annex II.2.2.2a and Supplementary information July 2017.
11 This section has been amended following the provisions of Article 8(6) and Article 18 of Regulation (EC) No 1831/2003.
12 Currently under re-evaluation according to Article 10(2) of Regulation (EC) No 1831/2003 of the European Parliament and of
the Council of 22 September 2003 on additives for use in animal nutrition. OJ L 268, 18.10.2003, p. 29.
13 Technical dossier/Section II/Annex II.1.3b.
14 Technical dossier/Supplementary information July 2017/Annex EM15_1_B. cereus.
15 Limit of detection: 1,000 CFU/g.
16 Technical dossier/Section II/Annex II.1.4.1.
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than 10 lm.17 The dusting potential of the same three batches of the additive, tested with a Heubach
Dustmeter, showed a mean value of 2 g/m3.18
3.1.3. Stability and homogeneity
The stability of three batches of EB15 10 packed in impermeable bags was monitored at 25, 30 and
37°C for 12 months.19 No viability losses were observed at any temperature during this period.
Three batches of EB15 mixed with two types of vitamin–mineral premixture (not containing choline
chloride) for piglets according to the conditions of use were stored for 6 months at 20–25°C.20 No
viability losses were detected.
To test stability at pelleting conditions, three batches of the EB15 were mixed with a pig mash feed,
in accordance with the conditions of use, and subjected to pelleting temperatures of 75, 85 and
95°C.21 Total counts of bacilli showed recovery equal or higher than 90% at the lowest temperatures
and of 78% at 95°C.
To test stability in feed for piglets, three batches of EB15 were mixed with mash and pelleted (at
95°C) feed in accordance with the conditions of use. Samples were stored for 6 months at 20–25°C.22
Total counts of bacilli showed recovery equal or higher than 90% in the mash feed and 80% in the
pelleted feed.
The stability of three batches of EB15 suspended in water for drinking at 20–25°C was tested after
one and two days, respectively. No viability losses were detected.23
The capacity of EB15 10 to homogeneously distribute in pelleted feed for piglets (based on 10
subsamples) according to the conditions of use was investigated in one study. Analyses of total counts
showed a coefﬁcient of variation of 0.9%.24
3.1.4. Conditions of use
The product is proposed for use in feed for weaned piglets and weaned minor porcine species at a
dose of 5 9 108 CFU/kg complete feedingstuffs and of 1.7 9 108 CFU/L of drinking water.
3.2. Safety
3.2.1. Safety for the target species, consumers and environment
The bacterial species B. subtilis is considered by EFSA to be suitable for the qualiﬁed presumption
of safety (QPS) approach to safety assessment (EFSA, 2007; EFSA BIOHAZ Panel, 2017). This
approach requires the identity of the strains to be conclusively established and evidence that the
strains lack toxigenic potential and do not show resistance to antibiotics of human and veterinary
importance.
In the view of the FEEDAP Panel, the identity of the active agent is established as B. subtilis and
the toxigenic potential and the antibiotic resistance qualiﬁcations have been met. Therefore, the strain
is presumed safe for the target species, consumer and the environment. EB15 10 is also considered
safe for target animals, consumers and the environment.
3.2.2. Safety for the user
No information was provided on the inhalation toxicity of the additive. The dustiness of the
preparations tested indicated a potential for users to be exposed via inhalation. A signiﬁcant fraction of
the product consists of ﬁne particles that have the potential to reach the alveoli when inhaled. Given
the proteinaceous nature of the active agent, the additive should be considered to be a potential
respiratory sensitiser. No data are available on skin/eye irritation or skin sensitisation. In the absence
of data, the FEEDAP Panel cannot conclude on the irritancy of EB15 10 to skin and eyes or on its
dermal sensitisation.
17 Technical dossier/Section II/Annex II.1.5a.
18 Technical dossier/Section II/Annex II.1.5b.
19 Technical dossier/Section II/Annexes II.4.1a and Annex_EB15_2_12mths.
20 Technical dossier/Section II/Annexes II.4.1d.
21 Technical dossier/Section II/Annex II.4.1b.
22 Technical dossier/Section II/Annexes II.4.1c.
23 Technical dossier/Section II/Annexes II.4.1e.
24 Technical dossier/Section II/Annexes II.4.2
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3.3. Efﬁcacy
3.3.1. Efﬁcacy for weaned piglets25
Six efﬁcacy studies were performed in three Member States and are described in the dossier.26
In all four studies considered, supplementation of EB15 led to a numerical greater weight gain,
however, reaching signiﬁcance only in one case (EB15 = 466 g/day vs control = 446 g/day, p < 0.05).
Feed to gain ratio was signiﬁcantly improved in two studies (EB15 = 1.56 g/g vs control = 1.64 g/g in
one study and EB15 = 1.52 g/g vs control = 1.65 g/g in the other study; p < 0.05). Mortality in the
treatment group was also signiﬁcantly lower in one study (EB15 = 2% vs control = 5.6%, p < 0.05).
Signiﬁcant differences on faecal scores27 were observed only in one study (EB15 = 7.42 vs
control = 7.23, p < 0.05).
Signiﬁcant effects were found only in two studies. Therefore, there is insufﬁcient evidence to
conclude on the efﬁcacy of EB15 in weaned piglets.
3.3.2. Efﬁcacy for weaned minor porcine species
In the absence of a demonstration of efﬁcacy for weaned piglets, no conclusions can be drawn for
minor porcine species.
3.4. Post-market monitoring
The FEEDAP Panel considers that there is no need for speciﬁc requirements for a post-market
monitoring plan other than those established in the Feed Hygiene Regulation28 and Good
Manufacturing Practice.
4. Conclusions
The active agent fulﬁls the requirements of the QPS approach to the assessment of safety,
consequently, EB15 10 is presumed safe for the target animals, consumers of products from treated
animals and the environment.
The additive should be considered a potential respiratory sensitiser. In the absence of data, the
FEEDAP Panel cannot conclude on the irritancy potential of the additive to skin and eyes or its dermal
sensitisation.
Insufﬁcient evidence was provided to conclude on the efﬁcacy of the additive in weaned piglets or
minor weaned porcine species.
Documentation provided to EFSA
1) EB15 (Bacillus subtilis DSM 25841) Zootechnical feed additive for weaned piglets and other
weaned minor porcine species + use in drinking water. November 2016. Submitted by Chr.
Hansen A/S
2) EB15 (Bacillus subtilis DSM 25841) Zootechnical feed additive for weaned piglets and other
weaned minor porcine species + use in drinking water. Supplementary information. July
2017. Submitted by Chr. Hansen A/S.
3) Evaluation report of the European Union Reference Laboratory for Feed Additives on the
Methods(s) of Analysis for EB15 10.
4) Comments from Member States.
25 This section has been amended following the provisions of Article 8(6) and Article 18 of Regulation (EC) No 1831/2003.
26 Technical dossier/Section IV/Annexes IV.3.1-6 and Supplementary information July 2017/Annex_EB15_5_vii.
27 Using a 10-point scale with 1 denoting severe diarrhoea, 9-10 denoting overly dry faeces and with 8 as optimal score.
28 Regulation (EC) No 183/2005 of the European Parliament and of the Council of 12 January 2005 laying down requirements for
feed hygiene. OJ L 35, 8.2.2005, p. 1.
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FEEDAP EFSA Panel on Additives and Products or Substances used in Animal Feed
OCDD octachlorodibenzo-p-dioxin
OCDF octachlorodibenzofuran
PCB polychlorinated biphenyl
PCDD polychlorinated dibenzodioxin/dibenzofuran
QPS qualiﬁed presumption of safety
TEQ toxic equivalent
EB15 10 for weaned piglets and minor porcine species
www.efsa.europa.eu/efsajournal 8 EFSA Journal 2018;16(4):5199
Annex A – Executive Summary of the Evaluation Report of the European
Union Reference Laboratory for Feed Additives on the Methods of Analysis
for EB15 10
In the current application authorisation is sought under Article 4(1) for Bacillus subtilis DSM 25841
under the category/functional group 4(b) ‘zootechnical additives’/‘gut ﬂora stabilisers’, according to
Annex I of Regulation (EC) No 1831/2003. Authorisation is sought for the use of the feed additive for
weaned piglets and weaned minor porcine species.
According to the Applicant, the feed additive contains as active substance viable spores of the non-
genetically modiﬁed strain Bacillus subtilis DSM 25841. The feed additive is to be marketed as a
powder containing a minimum Bacillus subtilis DSM 25841 content of 1.3 9 1010 Colony Forming Unit
(CFU)/g. The feed additive is intended to be used in drinking water at a minimum dose of
1.7 9 108 CFU/L, and directly in feedingstuffs or through premixtures at a minimum dose of
5 9 108 CFU/kg complete feedingstuffs.
For the identiﬁcation of Bacillus subtilis DSM 25841, the EURL recommends for ofﬁcial control
Pulsed Field Gel Electrophoresis (PFGE), a generally recognised methodology for genetic identiﬁcation
of bacterial strains.
For the enumeration of Bacillus subtilis DSM 25841 in feed additive, drinking water, premixtures
and feedingstuffs the Applicant submitted the ring-trial validated spread plate CEN method EN 15784.
Based on the performance characteristics available, the EURL recommends this method for ofﬁcial
control.
Further testing or validation of the methods to be performed through the consortium of National
Reference Laboratories as speciﬁed by Article 10 (Commission Regulation (EC) No 378/2005) is not
considered necessary.
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